Thursday, May 26, 2016 General News J E 4
Amanta Healthcare Ltd. is a manufacturer of Sterile Dosages covering Critical Care Fluid Therapy Respiratory Care and Eye Care products. Amanta launched today SteriPort - a new generation IV fluid system. Global standards such as Pharmaceutical Inspection Cooperation Scheme (PIC/s) and European Pharmacopeia (EP) have emphasized a lot on container integrity. Some of the most critical aspects are sterility transparency and closure system. Amongst others world over sterilization of container at 121 degrees C is a norm and a necessary condition to meet most of regulatory guidelines. 90% of IV fluids bottles in India do not comply. The other critical aspect is a closure system to ensure leak-free IV administration and supplementary medication without breaching the container integrity. The container has to be transparent so that any contamination in it can be detected before administrating. However the fact is that 85% - 90% of IV containers are neither meeting sterility requirement nor have necessary closure system and are at best translucent. SteriPort is a novel packaging concept. It has high sterility assurance level (sterilized at 121 degrees C) is as transparent as a glass container and has two port closure systems. Moreover the product and the process meet the global standards like Pharmaceutical Inspection Cooperation Scheme (PIC/s) and European Pharmacopeia (EP) on critical aspects like container integrity drug delivery compliances and drug compatibility. The unique feature of SteriPort is that it is compatible with most of the oncology products for IV administration which is not the case with polyethylene (PE) bottles. Speaking on the occasion Mr. Bhavesh Patel MD Amanta Healthcare said: “Innovation and adopting new concepts comes naturally.” SteriPort – is made of Random Co-Polymer (RCPP). This polymer resists temperature up to 125 degree C. It has superior tensile strength optical and barrier property.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
NUS Engineering team develops novel technology to ...
SIPPET, an international randomized study, reports...